Dignitana AB Appoints Nomination Committee
Dignitana Release - wkr0006.pdf
Dignitana, world leader in scalp cooling innovation, has appointed the Nomination Committee for the 2022 Annual General Meeting to be held 25 May 2022.
The Nomination Committee will consist of Greg Dingizian, Chairman of the Board and Owner of Adma Förvaltnings AB on closely related company’s mandate; Bo Lundgren, appointed by Swedbank Robur AB on closely related company mandate; and Klas Arildsson, Chairman of the Board of Dignitana AB.
The nomination committee shall give proposals for chairman at the AGM, election and remuneration of board members and, where applicable, remuneration for work in the board’s committees, election and remuneration of auditors and, where applicable, changes of principles for appointment of nomination committee.
Shareholders wishing to make suggestions to the nomination committee may write to investorrelations@dignitana.com by 1 April 2022 at the latest.
For More Information Contact
Melissa Bourestom, VP Corporate Communications, melissa.bourestom@dignitana.com +1 469-518-5031
About Dignitana
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.com or www.dignicap.com.
DigniCap long-term study demonstrates safety and efficacy of scalp cooling to reduce chemo hair loss
Dignitana expands customer service coverage in Europe with oneservice partnership
Dignitana expands partnership with Celeritas to improve scalp cooling technology available in Mexico
Dignitana announces proposal for Local Coverage Determination of scalp cooling therapy
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen